Recombinant hepatitis B vaccine for prevention of hepatitis B infection.
Artículo
en Inglés
| IMSEAR
| ID: sea-86456
ABSTRACT
Twenty-five resident doctors were given 1 ml (20 micrograms) of recombinant hepatitis B vaccine intramuscularly in the deltoid region at 0, 1 and 6 months. Seroconversion rates at 1, 2, 3, 7 and 8 months were 8%, 48%, 64%, 96% and 100% respectively. Acceptability of the vaccine was 100%. The recombinant hepatitis B vaccine is safe and efficacious, with seroconversion rates comparable to the plasma derived vaccine, and has negligible side effects.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Médicos
/
Factores de Tiempo
/
Proteínas Recombinantes
/
Femenino
/
Humanos
/
Masculino
/
Vacunas contra Hepatitis Viral
/
Vacunación
/
Vacunas contra Hepatitis B
/
Adulto
Idioma:
Inglés
Año:
1990
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS